America can either cede the future of biotechnology to our adversaries or summon the vision and resolve to lead it.

Sen. Bill Cassidy, MD (R-La.), chair of the committee, applauded medical innovations of the last few decades including ...

Editor’s Note: This deep dive was originally published Sept. 24, 2025, as a special edition of Biopharm Executive. Subscribe ...

The U.S. has ceded its leadership in critical industries before. It must not do so with China and biotech now, writes the ...

Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.

A mgen plans to invest more than $600 million in a new, state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks, California. The center is designed to bring ...

Takeda tightened its pipeline in the third quarter. Innovent Biologics reported a head-to-head win against semaglutide in a Chinese phase 3 trial. | Takeda tightened its pipeline in the third quarter.

CSL (ASX:CSL) has attracted fresh attention after its Broadmeadows plasma fractionation facility in Australia was named the ...

The 3D cell culture market is projected to witness remarkable expansion, reaching an estimated USD 2.26 billion by 2030 from ...

The upcoming EU Biotech Act may be more prominently focused on health. But it will also significantly impact food and food ...

As the EU prepares its first Biotech Act, experts say that Europe risks overlooking the role of biotechnology in food, a gap ...